268 related articles for article (PubMed ID: 19023126)
1. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting.
Barch DM; Carter CS; Arnsten A; Buchanan RW; Cohen JD; Geyer M; Green MF; Krystal JH; Nuechterlein K; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T; Heinssen R
Schizophr Bull; 2009 Jan; 35(1):109-14. PubMed ID: 19023126
[TBL] [Abstract][Full Text] [Related]
2. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models.
Moore H; Geyer MA; Carter CS; Barch DM
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2087-91. PubMed ID: 24090823
[TBL] [Abstract][Full Text] [Related]
3. CNTRICS final task selection: working memory.
Barch DM; Berman MG; Engle R; Jones JH; Jonides J; Macdonald A; Nee DE; Redick TS; Sponheim SR
Schizophr Bull; 2009 Jan; 35(1):136-52. PubMed ID: 18990711
[TBL] [Abstract][Full Text] [Related]
4. CNTRICS final task selection: executive control.
Barch DM; Braver TS; Carter CS; Poldrack RA; Robbins TW
Schizophr Bull; 2009 Jan; 35(1):115-35. PubMed ID: 19011235
[TBL] [Abstract][Full Text] [Related]
5. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.
Green MF; Butler PD; Chen Y; Geyer MA; Silverstein S; Wynn JK; Yoon JH; Zemon V
Schizophr Bull; 2009 Jan; 35(1):163-81. PubMed ID: 19023123
[TBL] [Abstract][Full Text] [Related]
6. CNTRICS imaging biomarkers selection: Working memory.
Barch DM; Moore H; Nee DE; Manoach DS; Luck SJ
Schizophr Bull; 2012 Jan; 38(1):43-52. PubMed ID: 22080498
[TBL] [Abstract][Full Text] [Related]
7. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.
Barch DM; Carter CS;
Schizophr Bull; 2008 Jul; 34(4):613-8. PubMed ID: 18499705
[TBL] [Abstract][Full Text] [Related]
8. CNTRICS final task selection: control of attention.
Nuechterlein KH; Luck SJ; Lustig C; Sarter M
Schizophr Bull; 2009 Jan; 35(1):182-96. PubMed ID: 19074499
[TBL] [Abstract][Full Text] [Related]
9. CNTRICS final task selection: social cognitive and affective neuroscience-based measures.
Carter CS; Barch DM; Gur R; Gur R; Pinkham A; Ochsner K
Schizophr Bull; 2009 Jan; 35(1):153-62. PubMed ID: 19011231
[TBL] [Abstract][Full Text] [Related]
10. CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning.
Ragland JD; Cohen NJ; Cools R; Frank MJ; Hannula DE; Ranganath C
Schizophr Bull; 2012 Jan; 38(1):62-72. PubMed ID: 22102094
[TBL] [Abstract][Full Text] [Related]
11. Perceptual measurement in schizophrenia: promising electrophysiology and neuroimaging paradigms from CNTRICS.
Butler PD; Chen Y; Ford JM; Geyer MA; Silverstein SM; Green MF
Schizophr Bull; 2012 Jan; 38(1):81-91. PubMed ID: 21890745
[TBL] [Abstract][Full Text] [Related]
12. Animal models and measures of perceptual processing in schizophrenia.
Siegel SJ; Talpos JC; Geyer MA
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2092-8. PubMed ID: 23867801
[TBL] [Abstract][Full Text] [Related]
13. CNTRICS final task selection: long-term memory.
Ragland JD; Cools R; Frank M; Pizzagalli DA; Preston A; Ranganath C; Wagner AD
Schizophr Bull; 2009 Jan; 35(1):197-212. PubMed ID: 18927344
[TBL] [Abstract][Full Text] [Related]
14. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.
Barch DM; Smith E
Biol Psychiatry; 2008 Jul; 64(1):11-7. PubMed ID: 18400207
[TBL] [Abstract][Full Text] [Related]
15. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
Carter CS; Barch DM
Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
[TBL] [Abstract][Full Text] [Related]
16. CNTRICS final animal model task selection: control of attention.
Lustig C; Kozak R; Sarter M; Young JW; Robbins TW
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2099-110. PubMed ID: 22683929
[TBL] [Abstract][Full Text] [Related]
17. Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research.
Gilmour G; Arguello A; Bari A; Brown VJ; Carter C; Floresco SB; Jentsch DJ; Tait DS; Young JW; Robbins TW
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2125-40. PubMed ID: 22548905
[TBL] [Abstract][Full Text] [Related]
18. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative.
Carter CS; Barch DM; Buchanan RW; Bullmore E; Krystal JH; Cohen J; Geyer M; Green M; Nuechterlein KH; Robbins T; Silverstein S; Smith EE; Strauss M; Wykes T; Heinssen R
Biol Psychiatry; 2008 Jul; 64(1):4-10. PubMed ID: 18466880
[TBL] [Abstract][Full Text] [Related]
19. Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia.
Dudchenko PA; Talpos J; Young J; Baxter MG
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt B):2111-24. PubMed ID: 22464948
[TBL] [Abstract][Full Text] [Related]
20. Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development.
Carter CS; Barch DM;
Schizophr Bull; 2012 Jan; 38(1):26-33. PubMed ID: 21914642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
